CompoAtlas

Adaptisol

Adaptisol, licence 80035544: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Concordia Partners LLC
NPN or DIN-HM
80035544
Status
Active licence
Licence date
19 September 2012
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Astragalus membranaceus

Source : Racine

466.6 mgNot calculated
Eleutherococcus senticosus

Source : Racine

Extraction ratio : 8:1

Dry plant equivalent : 1626.4 mg

203.3 mgNot calculated

Non-medicinal ingredients

Glycérine, Stéarate de magnésium, Hydroxypropylcellulose, Méthylcellulose, Dioxyde de silicium, Croscarmellose, Acide stéarique, phosphate de dicalcium, Microcrystalline cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1.0 Comprimé ; maximum: 3.0 Comprimé1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80035544

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line